These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2870639)

  • 1. Buspirone: review of its pharmacology and current perspectives on its mechanism of action.
    Eison AS; Temple DL
    Am J Med; 1986 Mar; 80(3B):1-9. PubMed ID: 2870639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and clinical effects of buspirone.
    Taylor DP; Eison MS; Riblet LA; Vandermaelen CP
    Pharmacol Biochem Behav; 1985 Oct; 23(4):687-94. PubMed ID: 2866549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buspirone hydrochloride: a unique new anxiolytic agent. Pharmacokinetics, clinical pharmacology, abuse potential and clinical efficacy.
    Goldberg HL
    Pharmacotherapy; 1984; 4(6):315-24. PubMed ID: 6151170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic.
    Goa KL; Ward A
    Drugs; 1986 Aug; 32(2):114-29. PubMed ID: 2874976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical pharmacology of buspirone hydrochloride.
    Skolnick P; Paul SM; Weissman BA
    Pharmacotherapy; 1984; 4(6):308-14. PubMed ID: 6151169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropharmacology of buspirone.
    Riblet LA; Eison AS; Eison MS; Taylor DP; Temple DL; VanderMaelen CP
    Psychopathology; 1984; 17 Suppl 3():69-78. PubMed ID: 6150510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buspirone, a novel nonbenzodiazepine anxiolytic.
    Kastenholz KV; Crismon ML
    Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropharmacological profile of buspirone: a non-benzodiazepine anxiolytic with specific mid-brain modulating properties.
    Leonard BE
    Br J Clin Pract Suppl; 1985 May; 38():74-82. PubMed ID: 2862907
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine and antianxiety activity.
    Taylor DP; Riblet LA; Stanton HC; Eison AS; Eison MS; Temple DL
    Pharmacol Biochem Behav; 1982; 17 Suppl 1():25-35. PubMed ID: 6135225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of gepirone, an aryl-piperazine anxiolytic drug, on aggressive behavior and brain monoaminergic neurotransmission.
    McMillen BA; Scott SM; Williams HL; Sanghera MK
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):454-64. PubMed ID: 2439924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and neurochemistry of buspirone.
    Riblet LA; Taylor DP; Eison MS; Stanton HC
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):11-8. PubMed ID: 6130068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buspirone: an anxioselective alternative for the management of anxiety disorders.
    Riblet LA; Eison AS; Eison MS; Newton RE; Taylor DP; Temple DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):663-8. PubMed ID: 6364236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of buspirone's anxiolytic action.
    Tunnicliff G
    Pharmacol Toxicol; 1991 Sep; 69(3):149-56. PubMed ID: 1796057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol and drug interactions with antianxiety medications.
    Schuckit MA
    Am J Med; 1987 May; 82(5A):27-33. PubMed ID: 2884873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buspirone and related compounds as alternative anxiolytics.
    Taylor DP; Moon SL
    Neuropeptides; 1991 Jul; 19 Suppl():15-9. PubMed ID: 1679210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buspirone: a new type of anxiolytic.
    Dommisse CS; DeVane CL
    Drug Intell Clin Pharm; 1985 Sep; 19(9):624-8. PubMed ID: 2864225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buspirone: an update on a unique anxiolytic agent.
    Jann MW
    Pharmacotherapy; 1988; 8(2):100-16. PubMed ID: 3041384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buspirone in the treatment of tardive dyskinesia.
    Ross CA
    Med Hypotheses; 1987 Mar; 22(3):321-8. PubMed ID: 2884555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical studies of buspirone.
    Schuckit MA
    Psychopathology; 1984; 17 Suppl 3():61-8. PubMed ID: 6150509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the safety and side effects of antianxiety agents.
    Schnabel T
    Am J Med; 1987 May; 82(5A):7-13. PubMed ID: 2884874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.